Option Care Health downgraded to Market Perform from Outperform at Citizens
Citizens analyst Constantine Davides downgraded Option Care Health (OPCH) to Market Perform from Outperform following an acquisition agreement by CD&R and McKesson (MCK) for $32.05 per share in cash.
How this was made
The 30-second read
Why it matters
The deal signals continued consolidation in the U.S. home‑health sector, with possible ripple effects on related service providers.
Market read
The downgrade and acquisition announcement provide immediate trading signals for OPCH and MCK.
What to watch
Potential regulatory scrutiny of the deal and integration challenges for McKesson.
Background
Option Care Health provides home health and hospice services; McKesson is a major pharmaceutical distributor.
Ticker impact
Citizens downgraded Option Care Health to Market Perform after announcing a $32.05 per share cash acquisition by McKesson and CD&R.
likely downward pressure as the market prices in the downgrade and acquisition premium.
Downgrades typically trigger sell‑offs; the cash deal may also cap upside.
McKesson (MCK) entered into an agreement with CD&R to acquire Option Care Health for $32.05 per share in cash.
potential modest upside as investors view the strategic expansion favorably.
Strategic acquisitions can be positively received, but integration risk tempers the reaction.
Market effects
Consolidation in the home‑health and pharmacy services sector may pressure peers.
U.S. healthcare services market sees increased M&A activity.
Limited to U.S. healthcare investors.
Counterpoint
The acquisition premium may be overstated; OPCH could be undervalued post‑deal.
Key entities
- CompanyOption Care Health
Target of the acquisition.
- CompanyMcKesson
Acquirer, a large pharmaceutical distributor.
- Research FirmCitizens
Analyst firm issuing the downgrade.
